InfuSystem Holdings

INFU

Market cap $188M

InfuSystem Holdings offers strong growth potential and appears attractively valued after reporting positive Q3 2025 earnings results. INFU's Patient Services segment, especially oncology and wound care, is driving revenue growth, while Device Solutions faced a temporary decline. Margin improvements, new contracts, and the Apollo acquisition are enhancing profitability and expanding INFU's market share and efficiency.

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025.

InfuSystem (INFU) is prioritizing profitability and margin expansion under new CEO Carrie Lachance, shifting focus from unprofitable revenue streams. INFU's integration of Apollo Medical's billing system and new ERP is expected to drive significant operational efficiencies and margin gains in FY2026. Capital discipline enables INFU to repurchase shares and reduce debt, while growth opportunities in Wound Care and Oncology remain robust.

The consensus price target hints at a 40% upside potential for InfuSystems Holdings (INFU). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

InfuSystem Holdings, Inc. ( INFU ) Q3 2025 Earnings Call November 4, 2025 9:00 AM EST Company Participants Carrie Lachance - President, CEO & Director Barry Steele - Executive VP & CFO Conference Call Participants Joe Dorame - Lytham Partners, LLC Kyle Bauser - ROTH Capital Partners, LLC, Research Division Tollef Kohrman - Craig-Hallum Capital Group LLC, Research Division James Sidoti - Sidoti & Company, LLC Benjamin Haynor - Lake Street Capital Markets, LLC, Research Division Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division Presentation Operator Good day, and welcome to the InfuSystem Third Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.

InfuSystems Holdings, Inc. (INFU) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.08 per share a year ago.

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem Reports Third Quarter 2025 Financial Results.

InfuSystem eyes third-quarter 2025 gains as rental contracts and ERP upgrades boost margins across Patient Services and Device Solutions.

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025.